A Study Evaluating the Bioavailability and Food Effect of Veliparib Tablets Followed by an Extension in Subjects With Ovarian Cancer

NCT03400306 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Strategic considerations

Conditions

Cancer - Ovarian

Interventions

DRUG: Veliparib, capsule
DRUG: Veliparib, tablet
DRUG: Carboplatin
DRUG: Paclitaxel

Sponsor

AbbVie